Luca Issi
Stock Analyst at RBC Capital
(1.75)
# 3,484
Out of 4,673 analysts
697
Total ratings
42.4%
Success rate
0.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintained: Hold | $45 → $130 | $145.13 | -10.43% | 40 | Aug 19, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $894.30 | - | 3 | Aug 18, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,025 → $1,100 | $1,039.78 | +5.79% | 13 | Aug 17, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $100 | $81.50 | +22.70% | 5 | Aug 14, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $280 → $290 | $253.29 | +14.49% | 17 | Aug 13, 2026 | |
| CRBU Caribou Biosciences | Maintained: Buy | $10 | $1.66 | +502.41% | 23 | Aug 13, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $9 | $2.09 | +330.62% | 33 | Aug 12, 2026 | |
| LXEO Lexeo Therapeutics | Maintained: Buy | $20 | $4.88 | +309.84% | 15 | Aug 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Hold | $62 | $66.70 | -7.05% | 37 | Aug 7, 2026 | |
| KRRO Korro Bio | Maintained: Hold | $8 → $10 | $13.18 | -24.13% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $10.72 | +77.24% | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $12.84 | +16.82% | 37 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $400 | $439.33 | -8.95% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $87.11 | +14.80% | 40 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $25.83 | +54.86% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.11 | +28.62% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $29.76 | -12.63% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $59.50 | -15.97% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $445 → $350 | $236.22 | +48.17% | 65 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $33.09 | -3.29% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.29 | +183.55% | 28 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $59.74 | +42.28% | 41 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $48.37 | +34.38% | 44 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $26.10 | +34.10% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $4 | $3.83 | +4.44% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.1423 | +1,305.48% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $14.34 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $54 | $15.97 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $4.68 | n/a | 7 | Mar 21, 2023 |
Moderna
Aug 19, 2026
Maintained: Hold
Price Target: $45 → $130
Current: $145.13
Upside: -10.43%
argenx SE
Aug 18, 2026
Maintained: Buy
Price Target: n/a
Current: $894.30
Upside: -
argenx SE
Aug 17, 2026
Maintained: Buy
Price Target: $1,025 → $1,100
Current: $1,039.78
Upside: +5.79%
BridgeBio Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $100
Current: $81.50
Upside: +22.70%
Ascendis Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $280 → $290
Current: $253.29
Upside: +14.49%
Caribou Biosciences
Aug 13, 2026
Maintained: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Allogene Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $9
Current: $2.09
Upside: +330.62%
Lexeo Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $20
Current: $4.88
Upside: +309.84%
BioMarin Pharmaceutical
Aug 7, 2026
Maintained: Hold
Price Target: $62
Current: $66.70
Upside: -7.05%
Korro Bio
Aug 7, 2026
Maintained: Hold
Price Target: $8 → $10
Current: $13.18
Upside: -24.13%
Aug 6, 2026
Maintained: Buy
Price Target: $19
Current: $10.72
Upside: +77.24%
Aug 6, 2026
Maintained: Hold
Price Target: $15
Current: $12.84
Upside: +16.82%
Aug 5, 2026
Maintained: Buy
Price Target: $370 → $400
Current: $439.33
Upside: -8.95%
Aug 5, 2026
Maintained: Buy
Price Target: $100
Current: $87.11
Upside: +14.80%
Aug 5, 2026
Maintained: Buy
Price Target: $40
Current: $25.83
Upside: +54.86%
Aug 5, 2026
Maintained: Hold
Price Target: $4
Current: $3.11
Upside: +28.62%
Aug 5, 2026
Reiterated: Hold
Price Target: $26
Current: $29.76
Upside: -12.63%
Aug 3, 2026
Maintained: Hold
Price Target: $50
Current: $59.50
Upside: -15.97%
Jul 30, 2026
Rated: Buy
Price Target: $445 → $350
Current: $236.22
Upside: +48.17%
Jul 30, 2026
Maintained: Hold
Price Target: $32
Current: $33.09
Upside: -3.29%
Jul 30, 2026
Maintained: Buy
Price Target: $15
Current: $5.29
Upside: +183.55%
Jul 29, 2026
Reiterated: Buy
Price Target: $85
Current: $59.74
Upside: +42.28%
Jul 29, 2026
Reiterated: Buy
Price Target: $65
Current: $48.37
Upside: +34.38%
Jul 29, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $26.10
Upside: +34.10%
Jun 2, 2026
Maintained: Hold
Price Target: $10 → $4
Current: $3.83
Upside: +4.44%
May 14, 2026
Maintained: Hold
Price Target: $2
Current: $0.1423
Upside: +1,305.48%
Nov 13, 2024
Maintained: Buy
Price Target: $9 → $11
Current: $14.34
Upside: n/a
May 11, 2023
Maintained: Hold
Price Target: $3 → $54
Current: $15.97
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $4 → $3
Current: $4.68
Upside: n/a